Insmed | INSM - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Cytokinetics USD 11.55B 3.36B 2026-06
DBV Technologies USD 1.23B 327M 2026-03
Gilead Sciences USD 156.86B 16.13B 2026-06
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 23.11B 12.19B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06